This State of Biotech session features John Sterling, GEN's Editor in Chief. After more than four decades and truly leaving his stamp on the biotech industry John has retired.
Here he reminisces about his time and GEN and the industry advances and changes over his tenure.
Credit to : GENNews
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.